Scinai Immunotherapeutics (SCNI) Net Cash Flow (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Net Cash Flow of $1.3 million for Q1 2026, up 240.41% on a YoY basis from $382774.3 in Q1 2025, and up 1770.51% sequentially from -$78000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Net Cash Flow (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Net Cash Flow data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 240.41% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $297000.0 (up 107.83% YoY), and the FY2025 full-year result was -$285000.0, up 90.19% from the prior year.
- Net Cash Flow climbed to $1.3 million in Q1 2026, from -$78000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $1.3 million in Q1 2026 to a low of -$4.2 million in Q2 2022.
- A 5-year average of -$1.4 million and a median of -$1.6 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow slumped 2220.0% in 2025 and soared 240.41% in 2026, its largest moves.
- Tracing SCNI's Net Cash Flow over 5 years: stood at -$863000.0 in 2022, then tumbled by 69.06% to -$1.5 million in 2023, then jumped by 161.69% to $900000.0 in 2024, then plunged by 108.67% to -$78000.0 in 2025, then jumped by 1770.51% to $1.3 million in 2026.
- Business Quant data shows SCNI's Net Cash Flow at $1.3 million in Q1 2026, -$78000.0 in Q2 2025, and -$928000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Jun 30, 2025 | -78,000.00 |
| Jun 30, 2025 | -78,000.00 |
| Mar 31, 2025 | -928,000.00 |
| Mar 31, 2025 | -928,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -40,000.00 |
| Mar 31, 2024 | -40,000.00 |
| Dec 31, 2023 | -1.46 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | -2.24 Mn |
| Sep 30, 2023 | -2.24 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -3.25 Mn |